SPEAKER FACULTY

Anton Pekcec

Director - CardioRenalMetabolic Diseases Research

Boehringer Ingelheim

Cory Schwartz

Director, Research & Early Development

iBio

David Bearss Ph.D.

President & Chief Executive Officer ,Co-Founder

Halia Therapeutics

David Tingley

Founder

Olio Labs

Dr. Raj Reddy

President & Chief Executive Officer

Canary Global

Francois Briand

Director, Research & Business Development

Physiogenex

Gary Barnette

Chief Scientific Officer

Veru Inc.

Gordon Foulkes

Chief Executive Officer

Lipidio Pharmaceuticals

Greg Luerman

Vice President, Research & Partnerships

CuriBio

Ilan Zipkin

Chief Executive Officer

Supercede Therapeutics

Jeremiah Bearss

Vice President - Clinical Development

Biolexis Therapeutics

John Mayer

Chief Scientific Officer

Ambrosia Biosciences

Julia Dunn

AVP

Eli Lily

Laurent Audoly

Chief Executive Officer

Prive Bio

Martin Marro

Executive Director

Eli Lily

Mitchell Steiner

Chairman, Chief Executive Officer & President

Veru Inc.

Olof Dahlqvist Leinhard

Chief Executive Officer & Co-Founder

Amra Medical

Patrice Lee

Head of R&D and Pharmacology

Ambrosia Biosciences

Robert Schott

Chief Medical Officer

Rivus Pharmaceuticals, Inc.

Sara Gry Vienberg

Director, Scientific Strategy

Novo Nordisk